Time course of cerebral blood flow changes following electroconvulsive therapy in depressive patients - Measured at 3 time points using single photon emission computed tomography

Keio Journal of Medicine

Volumn 55, Issue 4, 2006, Pages 153-160

  Takano, Harumasa ^a   Kato, Motoichiro ^a   Inagaki, Ataru ^a   Watanabe, Koichiro ^a   Kashima, Haruo ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Brain mapping; Depression; Electroconvulsive therapy (ECT); Single photon emission computed tomography (SPECT)

Indexed keywords

AMOXAPINE; BENZODIAZEPINE; CLOMIPRAMINE; MIANSERIN; MILNACIPRAN; NEUROLEPTIC AGENT; NORTRIPTYLINE; TRAZODONE;

ADULT; AGED; ANXIETY; ARTICLE; BRAIN BLOOD FLOW; BRAIN FUNCTION; CINGULATE GYRUS; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; ELECTROCONVULSIVE THERAPY; FEMALE; FRONTAL LOBE; HUMAN; INSOMNIA; LIMBIC CORTEX; MALE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUBICULUM; THERAPY EFFECT; TREATMENT DURATION; TREATMENT RESPONSE; BRAIN CIRCULATION; MIDDLE AGED; PATHOPHYSIOLOGY; SCINTISCANNING; TIME;

ADULT; AGED; CEREBROVASCULAR CIRCULATION; DEPRESSION; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 34247095519     PISSN: 00229717     EISSN: 18801293     Source Type: Journal    
DOI: 10.2302/kjm.55.153     Document Type: Article

References (31)

1. World Health Organization: The World Health Report 2001: Mental Health: New Understanding, New Hope, World Health Organization, 2001
2. Keller MB, Lavori PW, Mueller TI, Endicott J, Coryell W, Hirschfeld RM, Shea T: Time to recovery, chronicity, and levels of psychopathology in major depression. A 5-year prospective follow-up of 431 subjects. Arch Gen Psychiatry 1992; 49: 809-816
3. Abrams R: Electroconvulsive therapy, New York, Oxford University Press, 2002
4. American Psychiatric Association: Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry 2000; 157: 1-45
5. The UK ECT Review Group: Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet 2003; 361: 799-808
6. Drevets WC: Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Prog Brain Res 2000; 126: 413-431
7. Mayberg HS: Depression. In: Mazziottam JC, Toga AW, Frackowiak RSJ, eds, Brain Mapping: The Disorders, San Diego, Academic Press, 2000; 485-507
8. Motohashi N, Takano H, Uema T, Ogawa K, Nishikawa M, Ohnishi T, Matsuda H: Mechanisms of action of electroconvulsive therapy: investigations with PET and SPECT. In: Okuma T, Kanba S, Inoue Y, eds, Recent Advances in the Research of Affective Disorder in Japan, Tokyo, Elsevier Science, 2002; 185-194
9. Bonne O, Krausz Y, Shapira B, Bocher M, Karger H, Gorfine M, Chisin R, Lerer B: Increased cerebral blood flow in depressed patients responding to electroconvulsive therapy. J Nucl Med 1996; 37: 1075-1080
10. Vangu MD, Esser JD, Boyd IH, Berk M: Effects of electroconvulsive therapy on regional cerebral blood flow measured by 99mtechnetium HMPAO SPECT. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 15-19
11. Milo TJ, Kaufman GE, Barnes WE, Konopka LM, Crayton JW, Ringelstein JG, Shirazi PH: Changes in regional cerebral blood flow after electroconvulsive therapy for depression. J Ect 2001; 17: 15-21
12. Nobler MS, Sackeim HA, Prohovnik I, Moeller JR, Mukherjee S, Schnur DB, Prudic J, Devanand DP: Regional cerebral blood flow in mood disorders, III. Treatment and clinical response. Arch Gen Psychiatry 1994; 51: 884-897
13. Nobler MS, Oquendo MA, Kegeles LS, Malone KM, Campbell CC, Sackeim HA, Mann JJ: Decreased regional brain metabolism after ect. Am J Psychiatry 2001; 158: 305-308
14. Henry ME, Schmidt ME, Matochik JA, Stoddard EP, Potter WZ: The effects of ECT on brain glucose: a pilot FDG PET study. J Ect 2001; 17: 33-40
15. Yatham LN, Clark CC, Zis AP: A preliminary study of the effects of electroconvulsive therapy on regional brain glucose metabolism in patients with major depression. J Ect 2000; 16: 171-176
16. Mervaala E, Kononen M, Fohr J, Husso-Saastamoinen M, Valkonen-Korhonen M, Kuikka JT, Viinamaki H, Tammi AK, Tiihonen J, Partanen J, Lehtonen J: SPECT and neuropsychological performance in severe depression treated with ECT. J Affect Disord 2001; 66: 47-58
17. American Psychiatric Association: Diagnostic and statistical manual of mental disorders, Washington DC, American Psychiatric Press, 1994
18. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62
19. Folstein MF, Folstein SE, McHugh PR: "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198
20. American Psychiatric Association Committee on Electroconvulsive Therapy: The practice of electroconvulsive therapy, Washington DC, American Psychiatric Association, 2001
21. Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE: A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 1995; 36: 1238-1248
22. Talairach J, Tournoux P: Co-planar stereotaxic atlas of the human brain, Stuttgart, Thieme, 1988
23. Mizumura S, Kumita S, Cho K, Ishihara M, Nakajo H, Toba M, Kumazaki T: Development of quantitative analysis method for stereotactic brain image: assessment of reduced accumulation in extent and severity using anatomical segmentation. Ann Nucl Med 2003; 17: 289-295
24. Friston KJ: Statistical parametric mapping and other analyses of functional imaging data. In: Toga AW, Mazziotta JC, eds, Brain Mapping: The Methods, San Diego, Academic Press, 1996; 363-386
25. Ishii K, Willoch F, Minoshima S, Drzezga A, Ficaro EP, Cross DJ, Kuhl DE, Schwaiger M: Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains. J Nucl Med 2001; 42: 548-557
26. Scott AI, Dougall N, Ross M, O'Carroll RE, Riddle W, Ebmeier KP, Goodwin GM: Short-term effects of electroconvulsive treatment on the uptake of 99mTc-exametazime into brain in major depression shown with single photon emission tomography. J Affect Disord 1994; 30: 27-34
27. Volkow ND, Bellar S, Mullani N, Jould L, Dewey S: Effects of electroconvulsive therapy on brain glucose metabolism: a preliminary study. Convuls Ther 1988; 4: 199-205
28. Sackeim HA: The anticonvulsant hypothesis of the mechanisms of action of ECT: current status. J Ect 1999; 15: 5-26
29. Awata S, Konno M, Kawashima R, Suzuki K, Sato T, Matsuoka H, Fukuda H, Sato M: Changes in regional cerebral blood flow abnormalities in late-life depression following response to electroconvulsive therapy. Psychiatry Clin Neurosci 2002; 56: 31-40
30. Yuuki N, Ida I, Oshima A, Kumano H, Takahashi K, Fukuda M, Oriuchi N, Endo K, Matsuda H, Mikuni M: HPA axis normalization, estimated by DEX/CRH test, but less alteration on cerebral glucose metabolism in depressed patients receiving ECT after medication treatment failures. Acta Psychiatr Scand 2005; 112: 257-265
31. Navarro V, Gasto C, Lomena F, Mateos JJ, Portella MJ, Massana G, Bernardo M, Marcos T: Frontal cerebral perfusion after antidepressant drug treatment versus ECT in elderly patients with major depression: a 12-month follow-up control study. J Clin Psychiatry 2004; 65: 656-661